Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Mallinckrodt
Fuji
Farmers Insurance
US Department of Justice
Boehringer Ingelheim
US Army
Colorcon

Generated: May 23, 2018

DrugPatentWatch Database Preview

Natco Pharma Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for NATCO PHARMA LTD, and what generic and branded alternatives to NATCO PHARMA LTD drugs are available?

NATCO PHARMA LTD has eighteen approved drugs.

There is one tentative approval on NATCO PHARMA LTD drugs.

Summary for Natco Pharma Ltd

Drugs and US Patents for Natco Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203478-001 Jul 1, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Natco Pharma Ltd TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 091630-001 Nov 17, 2010 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Natco Pharma Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 201921-002 Dec 18, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Natco Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 202768-004 Sep 28, 2017 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Healthtrust
Merck
Chubb
Baxter
Moodys
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.